Ahead of her keynote at The Outlook on Active Nutrition, Michelle Arent, USC's Olympic sports performance nutrition director, shares her rigorous supplement vetting process, industry gaps in usability, and a preview of her presentation.
At the Future Nutra Innovation Summit, PLT Health's Steve Fink discusses joint, cognitive, and longevity nutrition explaining why "experiential longevity" is reshaping formulation strategy.
Live from the Future Nutra Innovation Summit, Kerry Hughes, founder and president of Ethnopharm, explains why botanicals' complex compound networks represent nutrition's next innovation frontier.
Nammex is bringing its already-introduced ErinaPrime Lion's mane mycelium ingredient, standardized to a specific neuroactive compound, to SupplySide Global.
Paul Eftang used his FNIS session to walk through lab data on lion's mane and Tongkat Ali products that pass identity and DNA testing while containing few or none of the bioactive compounds their marketing claims are based on.
At the Future Nutra Innovation Summit, Sibyl Swift, PhD, founder and principal of Swift Strategy Group, discusses supplement oversight and unpacks why mandatory product listing divides the industry.
Live from the Future Nutra Innovation Summit, Amber Thelen, director of technical services and innovation at Purity-IQ discusses strain-level verification gaps, NMR testing, and viability PCR for probiotic testing.